MPMichael Palmer

Michael Palmer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael Palmer has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Discovery of Highly Active Derivatives of Daptomycin by Assessing the Effect of Amino Acid Substitutions at Positions 8 and 11 on a Daptomycin Analogue

    by Ghufran Barnawi, Michael Noden, Jeremy Goodyear, Julian Marlyn, Olivia Schneider, David Beriashvili, Sarah Schulz, Ryan Moreira, Michael Palmer, Scott D. Taylor

    Daptomycin is an important antibiotic used for treating serious infections caused by Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci. Establishing structure–activity relationships of daptomycin is important for developing new daptomycin-based antibiotics with expanded clinical applications and for tackling the ever-increasing problem of antimicrobial resistance. Toward this end, Dap-K6-E12-W13, an active analogue of daptomycin in which the uncommon amino acids in daptomycin are replaced with their common counterparts, was used as a model system for studying the effect of amino acid variation at positions 8 and 11 on in vitro biological activity against a model organism, Bacillus subtilis, and calcium-dependent insertion into model membranes. None of the new peptides were more active than Dap-K6-E12-W13; however, substitution at positions 8 and/or 11 with cationic residues resulted in little or no loss of activity, and some of these analogues were able to insert into model membranes at lower calcium ion concentrations than the parent peptide. Incorporation of these cationic residues into positions 8 and/or 11 of daptomycin itself yielded some derivatives that exhibited lower minimum inhibitory concentrations than daptomycin against B. subtilis 1046 as well as comparable and sometimes superior activity against clinical isolates of MRSA.


  • Comprehensive Investigation of Metabolic Changes Occurring in the Rat Brain Hippocampus after Fluoxetine Administration Using Two Complementary In Vivo Techniques: Solid Phase Microextraction and Microdialysis

    by Ezel Boyaci, Sofia Lendor, Barbara Bojko, Nathaly Reyes-Garcés, Germán Augusto Gómez-Ríos, Mariola Olkowicz, Mustansir Diwan, Michael Palmer, Clement Hamani, Janusz Pawliszyn

    Fluoxetine is among the most prescribed antidepressant drugs worldwide. Nevertheless, limited information is known about its definitive mechanism. Although in vivo examinations performed directly in related brain structures can provide more realistic, and therefore more insightful, knowledge regarding the mechanisms and efficacy of this drug, only a few techniques are applicable for in vivo monitoring of metabolic alterations in the brain following an inducement. Among them, solid phase microextraction (SPME) and microdialysis (MD) have emerged as ideal in vivo tools for extraction of information from biosystems. In this investigation, we scrutinized the capabilities of SPME and MD to detect ongoing changes in the brain following acute fluoxetine administration. Sequential in vivo samples were collected simultaneously from male rats’ hippocampi using SPME and MD before drug administration in order to establish a baseline; then samples were collected again following fluoxetine administration for an investigation of small molecule alterations. Our results indicate that MD provides more comprehensive information for polar compounds, while SPME provides superior information with respect to lipids and other medium level polar molecules. Interestingly, in the lipidomic investigation, all dysregulated features were found to be membrane lipids and associated compounds. Moreover, in the metabolomic investigations, dysregulation of hippocampal metabolite levels associated with fatty acid transportation and purine metabolisms were among the most notable findings. Overall, our evaluation of the obtained data corroborates that, when used in tandem, SPME and MD are capable of providing comprehensive information regarding the effect of fluoxetine in targeted brain structures and further elucidating this drug’s mechanisms of action in the brain.


  • Investigation of Early Death-Induced Changes in Rat Brain by Solid Phase Microextraction via Untargeted High Resolution Mass Spectrometry: In Vivo versus Postmortem Comparative Study

    by Sofia Lendor, Mariola Olkowicz, Ezel Boyaci, Miao Yu, Mustansir Diwan, Clement Hamani, Michael Palmer, Nathaly Reyes-Garcés, German Augusto Gómez-Ríos, Janusz Pawliszyn

    Analysis of brain samples obtained post mortem remains a standard approach in neuroscience, despite often being sub-optimal for inferring roles of small molecules in the pathophysiology of brain diseases. Sample collection and preservation further hinders conclusive interpretation of biomarker analysis in autopsy samples. We investigate purely death-induced changes affecting rat hippocampus in the first hour of post mortem interval (PMI) by means of untargeted liquid chromatography-mass spectrometry-based metabolomics. The unique possibility of sampling the same brain area of each animal both in vivo and post mortem was enabled by employing solid phase microextraction (SPME) probes. 4 mm probes coated with mixed mode extraction phase were used to sample awake, freely roaming animals, with 2 more sampling events performed after death. Significant changes in brain neurochemistry were found to occur as soon as 30 minutes after death, and further progressing with increasing PMI, evidenced by relative changes in levels of metabolites and lipids. These included species from several distinct groups which can be classified as engaged in energy metabolism‐related processes, signal transduction, neurotransmission or inflammatory response. Additionally, we perform thorough analysis of inter-individual variability in response to death, which provides insights into how this aspect can obscure conclusions drawn from an untargeted study at single metabolite and pathway level. The results suggest high demand for systematic studies examining the PMI time course with in vivo sampling as a starting point to eliminate artifacts in the form of neurochemical changes assumed to occur in vivo.


  • Total Synthesis of Analogs of A54145D and A54145A1 for Structure–Activity Relationship Studies

    by Braden Kralt, Ryan Moreira, Michael Palmer, Scott D. Taylor

    The total solid phase synthesis and in vitro biological activity of a series of analogs of A54145 factor D (A5D) and A54145 factor A1 (A5A1), two cyclic lipodepsipeptide antibiotics, is reported. An on-resin cyclization strategy was employed to prepare A5A1 analogs in which Thr4, the residue involved in the depsi (ester) bond, was replaced with either diaminopropionic acid (DAPA), (2S,3R)-diaminobutyric acid (DABA), or serine, effectively replacing the ring closing ester bond with an amide linkage or with a primary ester. Antibacterial studies with these four analogs revealed that, contrary to a previous report, replacing the ester bond with an amide bond significantly reduces biological activity, and that both the ester bond and the methyl group at the γ-position of Thr4 are crucial for activity. Consistent with literature reports, we found that the single substitution of either 3-hydroxyasparagine (HOAsn) and 3-methoxyaspartate (MeOAsp) with Asn or Asp respectively in A5D, is more detrimental to activity than the double substitution where both HOAsn and MeOAsp are replaced with Asn or Asp respectively.


  • Total Synthesis of A54145 Factor D

    by Braden Kralt, Ryan Moreira, Michael Palmer, Scott D. Taylor

    An efficient total synthesis of A54145 factor D (A5D), a member of the A54145 family of cyclic lipodepsipeptide antibiotics is reported. The peptide was constructed by attaching the peptide to the 2’-chlorotrityl polystyrene resin via Sar5, and developing conditions that avoided diketopiperazine formation upon subsequent elaboration using Fmoc SPPS. This route allowed for facile formation of the crucial depsi bond. A branched acyclic precursor was cyclized off-resin then globally deprotected to obtain A5D. Consistent with recent studies by others, we found that the MeOAsp residue has the 2S,3R configuration. We also established that the configuration of the stereocenter in the anteiso-undecanoyl lipid tail does not affect biological activity.


  • Structure determination of the CAMP factor ofStreptococcus agalactiaewith the aid of an MBP tag and insights into membrane-surface attachment

    by Yajuan Li, Weihong Zeng, Yuelong Li, Weirong Fan, Huan Ma, Xiaojiao Fan, Jiansheng Jiang, Eric Brefo-Mensah, Yuzhu Zhang, Meixiang Yang, et al.

    CAMP factor is a unique α-helical bacterial toxin that is known for its co-hemolytic activity in combination with staphylococcal sphingomyelinase. It was first discovered in the human pathogenStreptococcus agalactiae(also known as group B streptococcus), but homologous genes have been found in many other Gram-positive pathogens. In this study, the efforts that led to the determination of the first structure of a CAMP-family toxin are reported. Initially, it was possible to produce crystals of the native protein which diffracted to near 2.45 Å resolution. However, a series of technical obstacles were encountered on the way to structure determination. Over a period of more than five years, many methods, including selenomethionine labeling, mutations, crystallization chaperones and heavy-atom soaking, were attempted, but these attempts resulted in limited progress. The structure was finally solved using a combination of iodine soaking and molecular replacement using the crystallization chaperone maltose-binding protein (MBP) as a search model. Analysis of native and MBP-tagged CAMP-factor structures identified a conserved interaction interface in the C-terminal domain (CTD). The positively charged surface may be critical for binding to acidic ligands. Furthermore, mutations on the interaction interface at the CTD completely abolished its co-hemolytic activities. This study provides novel insights into the mechanism of the membrane-permeabilizing activity of CAMP factor.


  • Total Synthesis of Paenibacterin and Its Analogues

    by Michael Noden, Ryan Moreira, En Huang, Ahmed Yousef, Michael Palmer, Scott D. Taylor

    Paenibacterin is a recently discovered cyclic lipodepsipeptide antibiotic produced by the soil bacterium Paenibacillus thiaminolyticus. It is produced as a mixture of three compounds with isomeric 15-carbon acyl lipids, designated P-A1 (linear lipid), P-A2 (anteiso lipid), and P-A3 (iso lipid). Here, we report the total synthesis of P-A1 and P-A2, as well as two analogues of P-A1 in which the threonine residue in P-A1 was replaced with l-2,3-diaminopropionic acid (P-A1-Dapa) and (2S,3R)-2,3-diaminobutyric acid (P-A1-Daba), converting the ring-closing ester bond to an amide bond. Solid phase peptide chemistry was used to prepare branched precursors which were cyclized off-resin to obtain the target peptides in good to excellent overall yields. The use of a pseudoproline dipeptide building block was found to be important for obtaining good yields. The antibacterial activity of the peptides was determined against Escherichia coli K-12 (G–) and Bacillus subtilis 1046 (G+). The minimum inhibitory concentrations of P-A1 and P-A2 were the same despite the variation in the structure of the acyl tail. Replacing the ring-closing ester bond with an amide bond had little or no effect on activity. The synthetic routes developed here should prove to be useful for creating new antibiotics based on the structure of paenibacterin.


  • The effect of replacing the ester bond with an amide bond and of overall stereochemistry on the activity of daptomycin

    by Ryan Moreira, Ghufran Barnawi, David Beriashvili, Michael Palmer, Scott D. Taylor


  • Mechanistic studies on the effect of membrane lipid acyl chain composition on daptomycin pore formation

    by David Beriashvili, Robert Taylor, Braden Kralt, Nooran Abu Mazen, Scott D. Taylor, Michael Palmer